Pharmaceutical Technology5h
Liraglutide by Novo Nordisk for Obesity: Likelihood of Approval
Liraglutide is under development for the treatment of obesity, ileal pouch-anal anastomosis and Alzheimer's disease. It was also under development for non-alcoholic steatohepatitis, psoriatic ...
Pharmaceutical Technology5h
Liraglutide by Novo Nordisk for Alzheimer’s Disease: Likelihood of Approval
Liraglutide is under development for the treatment of obesity, ileal pouch-anal anastomosis and Alzheimer's disease. It was also under development for non-alcoholic steatohepatitis, psoriatic ...
How is India transforming the global biopharma landscape?
India's biopharma sector marked notable achievements, with approvals of key biosimilars and the launch of advanced CAR-T ...
McKnight's Long-Term Care News13h
FDA approves first generic liraglutide once-daily injection
The US Food and Drug Administration has approved the first generic referencing Victoza (liraglutide; Hikma Pharmaceuticals), ...
Businessworld19h
no documents live casino
INR:8252. no documents live casino Hanyu Pharmaceuticals' "Liraglutide Injection" is listed in Category 4 Approved for clinical trials! I-Mab's TJM2 trea ...
Businessworld20h
tam vs mum kabaddi
INR:0921. tam vs mum kabaddi Hanyu Pharmaceuticals' "Liraglutide Injection" is listed in Category 4 R&D Daily丨UCB's new anti-epileptic drug padsevonil failed ...